FEBS Letters (ERA Journal)
FEBS Letters is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.
FEBS Letters issns are issn1: 0014-5793 issn2: 1873-3468.
The fields covered by FEBS Letters as part of the evaluation of Australian university research excellence are:
Medicinal and Biomolecular Chemistry Research Rankings (Sub-Field)
Biochemistry and Cell Biology Research Rankings (Sub-Field)
Evolutionary Biology Research Rankings (Sub-Field)
Other ERA-accredited journals supporting the evaluation of the Medicinal and Biomolecular Chemistry field include:
- Amino Acids
- Anti-Cancer Agents in Medicinal Chemistry
- Anti-Cancer Drugs: international journal on anti-cancer agents
- Assay and Drug Development Technologies
- Biocatalysis and Biotransformation
- Biochemistry
- Biomaterials Science
- Bioorganic and Medicinal Chemistry Letters
- European Journal of Mass Spectrometry
- Journal of Cellular and Molecular Medicine
- Journal of Molecular Medicine
- Journal of Molecular Modeling
- Journal of Pharmacology and Toxicology
- Pharmacology Research and Perspectives
- Vibrational Spectroscopy
ERA Research Rankings Submenu
- ERA 2018 Outcomes Research Rankings List
- ERA 2018 Research Rankings Analysis
- ERA 2018 Individual University Outcomes List
- ERA List of Research Fields Rankings
- ERA Journal Rankings 2018 List
Latest News and Updates:
- Top 10 Best Australian Universities
- Gender Balance Male-Female Ratio
- ERA 2018 Outcomes Research Rankings List
- University Bachelor Degree Completion Rates
- QS Employability Rankings Australian Universities
- ARWU World Rankings of Australian Universities
- Group of Eight (go8) World Rankings